WO2019004748A3 - 페리오스틴을 이용한 아이소사이아네이트 직업성 천식의 진단방법 - Google Patents

페리오스틴을 이용한 아이소사이아네이트 직업성 천식의 진단방법 Download PDF

Info

Publication number
WO2019004748A3
WO2019004748A3 PCT/KR2018/007348 KR2018007348W WO2019004748A3 WO 2019004748 A3 WO2019004748 A3 WO 2019004748A3 KR 2018007348 W KR2018007348 W KR 2018007348W WO 2019004748 A3 WO2019004748 A3 WO 2019004748A3
Authority
WO
WIPO (PCT)
Prior art keywords
diagnosis
occupational asthma
periostin
isocyanate
present
Prior art date
Application number
PCT/KR2018/007348
Other languages
English (en)
French (fr)
Other versions
WO2019004748A2 (ko
WO2019004748A9 (ko
Inventor
박해심
이지호
최영우
겐지이주하라
Original Assignee
아주대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아주대학교산학협력단 filed Critical 아주대학교산학협력단
Publication of WO2019004748A2 publication Critical patent/WO2019004748A2/ko
Publication of WO2019004748A3 publication Critical patent/WO2019004748A3/ko
Publication of WO2019004748A9 publication Critical patent/WO2019004748A9/ko

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/40—Disorders due to exposure to physical agents, e.g. heat disorders, motion sickness, radiation injuries, altitude sickness, decompression illness

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

본 발명은 페리오스틴(periostin)을 이용한 직업성 천식의 진단을 위한 정보제공 방법에 관한 것이다. 더욱 상세하게는 TDI에 노출된 집단의 혈액 내 페리오스틴 농도를 측정하는 단계를 포함하는 직업성 천식의 진단을 위한 정보제공 방법에 관한 것이다. 본 발명에 따르면, 혈액 내 페리오스틴 농도 측정을 통해 직업성 천식을 조기에 진단하고 치료함으로써 직업성 천식 환자의 예후를 향상시킬 수 있다.
PCT/KR2018/007348 2017-06-30 2018-06-28 페리오스틴을 이용한 아이소사이아네이트 직업성 천식의 진단방법 WO2019004748A2 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020170083618A KR101967826B1 (ko) 2017-06-30 2017-06-30 페리오스틴을 이용한 아이소사이아네이트 직업성 천식의 진단방법
KR10-2017-0083618 2017-06-30

Publications (3)

Publication Number Publication Date
WO2019004748A2 WO2019004748A2 (ko) 2019-01-03
WO2019004748A3 true WO2019004748A3 (ko) 2019-03-28
WO2019004748A9 WO2019004748A9 (ko) 2019-05-16

Family

ID=64742462

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2018/007348 WO2019004748A2 (ko) 2017-06-30 2018-06-28 페리오스틴을 이용한 아이소사이아네이트 직업성 천식의 진단방법

Country Status (2)

Country Link
KR (1) KR101967826B1 (ko)
WO (1) WO2019004748A2 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102527520B1 (ko) 2020-09-16 2023-05-03 순천대학교 산학협력단 직업성 천식 진단용 조성물 및 이를 이용한 직업성 천식 진단방법

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100131003A (ko) * 2008-03-31 2010-12-14 제넨테크, 인크. 천식을 치료 및 진단하기 위한 조성물 및 방법
KR101114033B1 (ko) * 2009-04-10 2012-02-21 아주대학교산학협력단 단일염기다형을 포함하는 폴리뉴클레오티드, 이를 포함하는 마이크로어레이 및 진단키트, 및 이를 이용한 분석방법

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100131003A (ko) * 2008-03-31 2010-12-14 제넨테크, 인크. 천식을 치료 및 진단하기 위한 조성물 및 방법
KR101114033B1 (ko) * 2009-04-10 2012-02-21 아주대학교산학협력단 단일염기다형을 포함하는 폴리뉴클레오티드, 이를 포함하는 마이크로어레이 및 진단키트, 및 이를 이용한 분석방법

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
OH, SUNG SOO: "Occupational asthma in Korea", JOURNAL OF KOREAN MEDICAL SCIENCE, 2010, XP055586164 *
SHANSHAN ET AL.: "Levels and significance of serum periostin and Ig E in workers exposed to 6-APA, 7-ACA", CHINESE JOURNAL OF INDUSTRIAL MEDICINE, April 2017 (2017-04-01), pages 98 - 101, XP055586162 *
SIM, DA WOON ET AL.: "Biomarkers of adult asthma and personalized medicine", ALLERGY ASTHMA & RESPIRATORY DISEASE, vol. 4, no. 1, 2016, pages 4 - 13, XP055586179 *

Also Published As

Publication number Publication date
WO2019004748A2 (ko) 2019-01-03
WO2019004748A9 (ko) 2019-05-16
KR20190003117A (ko) 2019-01-09
KR101967826B1 (ko) 2019-04-11

Similar Documents

Publication Publication Date Title
AU2017225061B2 (en) Biomarkers and methods of treating PD-1 and PD-L1 related conditions
MX2019003473A (es) Metodos mejorados para evaluar el estado de ubiquitin carboxi-terminal hidrolasa l1 (uch-l1) en muestras de pacientes.
MX2018009304A (es) Metodos de diagnostico y pronostico para episodios y enfermedades cardiovasculares.
MX2019004931A (es) Comparacion disimetrica de valores de humedad subepidermica.
MX2021012347A (es) Composiciones, metodos y kits para el diagnostico de una neoplasia neuroendocrina gastroenteropancreatica.
MX2017008904A (es) Biomarcadores basados en sangre para diagnosticar enfermedad de arteria coronaria ateroesclerotica.
WO2012018535A3 (en) Wellness panel
WO2017070114A3 (en) Diabetes-related biomarkers and treatment of diabetes-related conditions
NZ703411A (en) Use of markers in the diagnosis and treatment of prostate cancer
NZ729773A (en) Biomarkers for disease progression in melanoma
MX2018001697A (es) Método para la cuantificación de los miembros del filogrupo i y/o del filogrupo ii de faecalibacterium prausnitzii y el uso de los mismos como biomarcadores.
MX2019008911A (es) Metodos, matrices y usos de estos.
BR112018011224A2 (pt) processo de avaliação do risco de complicações nos pacientes que apresentam uma síndrome da resposta inflamatória sistêmica (sirs)
EP3707523A4 (en) BODY WEARABLE BLOOD ANALYTE MEASURING DEVICE AND METHOD OF MEASURING BLOOD ANALYTE CONCENTRATION
WO2019004748A3 (ko) 페리오스틴을 이용한 아이소사이아네이트 직업성 천식의 진단방법
IN2012DN02058A (ko)
BR112012024175A2 (pt) hbf e a1m como marcadores de estágio precoce para preeclampsia
WO2013009143A3 (ko) 당뇨망막병증 진단용 마커 및 이의 용도
NZ609324A (en) Biomarker for alzheimer’s disease or mild cognitive impairment
WO2014198670A3 (en) Methods of viewing and analyzing high content biological data
ATE550443T1 (de) Matrix-marker-modell und verfahren zur überprüfung und behandlung von rheumatischer arthritis
MX2018011679A (es) Biomarcadores de proteopatias y usos de los mismos.
MX2013009209A (es) Metodo para analizar placa.
AU2015205151A1 (en) 5-hydroxy-1H-imidazole-4-carboxamide effective-dose/sensitivity prediction method and prediction device, xanthosine-monophosphate-amount measurement method, and myelodysplastic-syndrome treatment agent and treatment method
WO2014042148A8 (ja) がんマーカーおよびその用途

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18822681

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18822681

Country of ref document: EP

Kind code of ref document: A2